| dc.creator |
Erdogan, Dogan |
|
| dc.creator |
Muderrisoglu, HaIdun |
|
| dc.creator |
Gullu, Hakan |
|
| dc.creator |
Caliskan, Mustafa |
|
| dc.date |
2008-11-01T01:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:31:01Z |
|
| dc.date.available |
2021-12-03T11:31:01Z |
|
| dc.identifier |
7bbb1046-a1a5-41f8-aae7-9f9bea7f92c0 |
|
| dc.identifier |
10.1016/j.atherosclerosis.2008.01.010 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/7bbb1046-a1a5-41f8-aae7-9f9bea7f92c0/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/92891 |
|
| dc.description |
Background: Patients with idiopathic dilated cardiomyopathy (IDC) have impaired coronary flow reserve (CFR) and reduced CFR has been reported to be a poor prognostic indicator and independent predictor of subsequent cardiac events in patients with IDC. Serum gamma-glutamyltransferase (GGT) level is an independent risk factor for cardiovascular disease. Therefore, we aimed to determine whether serum GGT level is associated with CFR impairment in patients with IDC. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Higher serum gamma-glutamyltransferase levels are independently associated with impaired coronary microvascular function in patients with dilated cardiomyopathy |
|
| dc.type |
info:eu-repo/semantics/article |
|